Kaliumchlorid/Natriumchlorid B. Braun

Potassium chloride and sodium chloride, the active ingredients in Kaliumchlorid/Natriumchlorid B. Braun, are electrolyte solutions presented as an intravenous solution for intravenous use. They restore deficient potassium and sodium ions, helping to correct hypokalemia, hyponatremia, and support overall fluid and electrolyte balance in hospitalized patients requiring careful monitoring in clinical settings. Administration is performed under physician supervision to ensure safe electrolyte correction.

GNH USA supplies Kaliumchlorid/Natriumchlorid B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Kaliumchlorid/Natriumchlorid B. Braun is used as an intravenous electrolyte solution to correct specific ion deficiencies. - Electrolyte replacement: restores potassium and sodium levels in patients with overall electrolyte depletion. - Hypokalemia: raises low serum potassium concentrations to normal range. - Hyponatremia: increases serum sodium to correct dilutional hyponatremia. - Fluid and electrolyte balance maintenance: supports ongoing fluid therapy in postoperative or critically ill patients.

Kaliumchlorid/Natriumchlorid may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Injection site pain: mild discomfort at the infusion site. - Phlebitis: inflammation of the vein used for administration. - Nausea: transient feeling of queasiness. - Hyperkalemia: elevated serum potassium if infused rapidly.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm due to electrolyte imbalance. - Severe hyperkalemia: life‑threatening potassium excess causing muscle weakness. - Anaphylactic reaction: rare hypersensitivity with rash, bronchospasm, or hypotension.

When using Kaliumchlorid/Natriumchlorid, clinicians should observe specific precautions to minimize risks. - Patient assessment: evaluate serum potassium and sodium levels before initiation. - Infusion rate: administer at a controlled rate to avoid rapid electrolyte shifts. - Cardiac monitoring: observe ECG for arrhythmias during and after infusion. - Concomitant drugs: adjust dosage when used with other potassium‑sparing agents or diuretics. - Renal function: assess kidney function as impaired clearance may increase risk of accumulation. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kaliumchlorid/Natriumchlorid can interact with other medications, influencing electrolyte balance or cardiac function.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may potentiate hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of severe hyperkalemia. - Sodium‑containing IV fluids: can cause hypernatremia if combined excessively.

Moderate Interactions (Monitor Closely): - Digoxin: electrolyte shifts can alter its therapeutic window. - Beta‑blockers: may mask signs of hypoglycemia in patients with electrolyte disturbances. - NSAIDs: can impair renal excretion of potassium, requiring monitoring.